99 results on '"Garcia, David"'
Search Results
2. Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy
3. Acquired Hemophilia Following COVID-19 and Influenza Vaccination: A Systematic Review
4. "Autoimmune HIT", a Potential Diagnostic Artifact Due to Remnant Heparin in HIT Samples, Is Not Associated with More Severe Outcomes
5. Idiopathic Multicentric Castleman's Disease with Concurrent Renal Involvement
6. Utilization of Natural Language Processing in Venous Thromboembolism Identification
7. Thrombophilia Testing Patterns, Result Interpretation, and Clinical Outcomes in a Retrospective Cohort of Patients with Retinal Vascular Occlusion
8. Derivation and External Validation of Clinical Risk Assessment Model for Cancer Associated Thrombosis in Two Unique U.S. Healthcare Systems
9. Impact of Race/Ethnicity on Cancer Associated Thrombosis Among Underserved Patients with Cancer
10. Optimizing Cancer Associated Thrombosis (CAT) Risk Assessment Model at a Safety-Net Healthcare System
11. Internal and External Validation of the High-2-Low Model: A Predictive Score for Venous Thromboembolism after Allogeneic Transplant
12. A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations
13. A prospective, blinded study of a PF4-dependent assay for HIT diagnosis
14. HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment
15. Does aspirin prevent venous thromboembolism?
16. Comparison of Outcomes and Utilization of Therapy in Multiple Myeloma Patients in the USA and Alberta, Canada
17. Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study
18. High-2-Low Risk Assessment Model to Predict Venous Thromboembolism in Allogeneic Transplant Patients after Platelet Engraftment
19. Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study
20. Systems-based hematology: highlighting successes and next steps
21. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes
22. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients
23. Comparative Effectiveness of Rasburicase Versus Allopurinol for Cancer Patients with Renal Dysfunction and Hyperuricemia
24. D-Dimer As a Prognostic Biomarker for Venous Thromboembolism after Hematopoietic Cell Transplantation
25. Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis
26. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma
27. The Association between Transplant-Associated Thrombotic Microangiopathy and Calcineurin Inhibitor and Sirolimus Levels
28. Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta-Analysis
29. The HAS-RISC Score for Venous Thromboembolism (VTE) Risk Stratification in Newly Diagnosed Multiple Myeloma Patients Starting Immunomodulatory Drugs (IMID)
30. The Platelet Factor-4 (PF4)-Dependent p-Selectin Expression Assay (PEA) Is Highly Accurate for the Detection of Pathogenic HIT Antibodies: Results of a 440-Sample Prospective Blinded Study
31. Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)
32. The Incidence of Thromboembolism for Lenalidomide Versus Thalidomide in Older Patients with Newly Diagnosed Multiple Myeloma
33. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome
34. The case against catheter-directed thrombolysis in patients with proximal deep vein thrombosis
35. The Khorana Score for the Prediction of Venous Thromboembolism in Patients with Solid Cancer: An Individual Patient Data Meta-Analysis
36. Monoclonal Gammopathies: Electronic Subspecialty Consultation
37. A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study
38. An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients
39. Transplant-Associated Thrombotic Microangiopathy (TA-TMA): Not a Singular Entity
40. Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation
41. Improving Our Ability to Treat Patients with Qualitative and Quantitative Platelet Disorders
42. Association of BW with Thromboembolic and Bleeding Outcomes in Phase III Randomized Controlled Trials of Direct Oral Anticoagulants: Systematic Review and Meta-Analysis
43. A Platelet Count <50 x109 Was Not Associated with Increased Rates of Major Bleeding Among Anticoagulated Patients
44. Management of Anticoagulation in Patients with Hematologic Malignancy Undergoing Autologous Hematopoietic Cell Transplantation
45. Corticosteroids for ITP: A Comparison of Two Approaches
46. Short-Term Treatment Strategies for Recurrent Venous Thromboembolism
47. Management of Venous Thromboembolism: An Update of the ACCP Guidelines
48. Practice-Defining Clinical Trials in Nonmalignant Hematology
49. Testing a Novel Approach to Chemotherapy-Associated Thrombocytopenia
50. A New, Uninhibited Approach to the Treatment of Hemophilia A
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.